NX Development - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsNX Development

NX Development

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Gleolan	Aminolevulinic acid	2017-06-06	2028-2040	Actinic keratosis

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

Aminolevulinic acid

,

oligodendroglioma

,

wound infection

,

surgical wound infection

,

prostheses and implants

,

prosthesis-related infections

,

healthy volunteers/patients

,

,

,

pharmacokinetics

,

,

seborrheic dermatitis

,

ulcerative colitis

,

,

,

,

carcinoma in situ

,

photochemotherapy

,

,

uterine cervical dysplasia

,

colorectal neoplasms

,

central nervous system neoplasms

,

squamous intraepithelial lesions

,

basal cell nevus syndrome

,

neurofibromatoses

,

colonic neoplasms

,

cervical intraepithelial neoplasia

,

t-cell lymphoma cutaneous

,

,

mouth neoplasms

,

mycosis fungoides

,

,

nervous system neoplasms

,

head and neck neoplasms

,

oral leukoplakia

,

papillomavirus infections

,

malignant mesothelioma

,

,

neurofibromatosis 1

,

,

,

,

,

,

sezary syndrome

,

b-cell chronic lymphocytic leukemia

,

skull base neoplasms

,

vulvar neoplasms

,

diffuse intrinsic pontine glioma

,

,

oral lichen planus

,

squamous cell carcinoma of head and neck

,

kidney neoplasms

,

aortic valve disease

,

coronary artery bypass

,

mitral valve insufficiency

,

cardiac surgical procedures

,

adult t-cell leukemia-lymphoma

,

precursor t-cell lymphoblastic leukemia-lymphoma

,

,

brain neoplasms

,

basal cell neoplasms

,

squamous cell carcinoma

,

precancerous conditions

,

,

,

squamous cell neoplasms

,

breast neoplasms

,

,

postoperative complications

,

,

shoulder injuries

,

,

propionibacterium acnes

,

,

male breast neoplasms

,

,

,

ovarian neoplasms

,

actinic keratosis

,

,

,

basal cell carcinoma

,

urinary bladder neoplasms

,

,

,

,

bowen's disease

,

,

non-muscle invasive bladder neoplasms

,

,

transitional cell carcinoma

,

hutchinson's melanotic freckle

,

,

connective tissue diseases

,

invasive hydatidiform mole

,

,

communicable diseases

,

neoplasm metastasis

,

type 2 diabetes mellitus

,

,

,

erythropoietic porphyria

,

,

sleep initiation and maintenance disorders

,

psychological adaptation

,

,

environmental biomarkers

,

,

,

pituitary neoplasms

,

critical illness

,

condylomata acuminata

,

diabetes mellitus

,

,

,

pigmented nevus

,

porphyria cutanea tarda

,

acute intermittent porphyria

,

erythropoietic protoporphyria

,

iron-deficiency anemia

,

hereditary coproporphyria

,

hepatic porphyrias

,

wounds and injuries

,

,

vulvar lichen sclerosus

,

hypertrophic cicatrix

,

,

residual neoplasm

,

neuroepithelial neoplasms

,

neuroectodermal tumors

,

squamous intraepithelial lesions of the cervix

,

respiratory tract infections

,

non-small-cell lung carcinoma

,

surgical amputation

,

osseointegration

,

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use